Oncogenic BRAF and KRAS mutations in endosalpingiosis.
Oncogenic BRAF and KRAS mutations in endosalpingiosis.
复制标题
DOI:
10.1002/path.5353
复制
发表时间:
2020-02
期刊:
影响因子:
--
通讯作者:
Shih IM
中科院分区:
文献类型:
--
作者:
Chui MH;Shih IM
Endosalpingiosis, a microscopic lesion composed of ectopic Fallopian tube epithelium, frequently involves the peritoneum and lymph nodes in patients with ovarian serous borderline tumour or low-grade serous carcinoma, but its pathogenic significance remains unclear. Using laser-capture microdissection and droplet digital PCR, we investigated whether endosalpingiosis harbours the driver mutations in BRAF and KRAS that characterise ovarian low-grade serous neoplasms. Somatic mutations were detected in 14 (33%) of 43 endosalpingiotic lesions analysed. Of 21 women with endosalpingiosis associated with a synchronous or metachronous ovarian low-grade serous tumour, mutations were identified in endosalpingiotic lesions from 11 (52%) women, with most cases (10/11, 91%) demonstrating identical mutations in both tumour and endosalpingiosis. In contrast, of 13 cases of endosalpingiosis not associated with an ovarian tumour, only one harboured a KRAS mutation. The proliferative activity as assessed by Ki-67 immunohistochemistry was lower in endosalpingiosis than in low-grade serous tumours, and endosalpingiosis with either a BRAF or KRAS mutation had a significantly lower Ki-67 index than those without. Ectopic expression of KRASG12V in Fallopian tube epithelial cells led to ERK phosphorylation, p21 induction, growth arrest and cellular senescence. In conclusion, we demonstrate that endosalpingiosis represents an interesting example of cancer driver mutations in deceptively normal-appearing cells, which may be prone to neoplastic transformation upon bypass of endogenous oncosuppressive mechanisms.
登录
查看更多内容
DOI:
10.1097/pas.0000000000000313
发表时间:
2014-12
期刊:
The American journal of surgical pathology
影响因子:
--
作者:
Zeppernick F;Ardighieri L;Hannibal CG;Vang R;Junge J;Kjaer SK;Zhang R;Kurman RJ;Shih IeM
通讯作者:
Shih IeM
DOI:
10.1056/nejmoa1614814
发表时间:
2017-05-11
期刊:
The New England journal of medicine
影响因子:
--
作者:
Anglesio MS;Papadopoulos N;Ayhan A;Nazeran TM;Noë M;Horlings HM;Lum A;Jones S;Senz J;Seckin T;Ho J;Wu RC;Lac V;Ogawa H;Tessier-Cloutier B;Alhassan R;Wang A;Wang Y;Cohen JD;Wong F;Hasanovic A;Orr N;Zhang M;Popoli M;McMahon W;Wood LD;Mattox A;Allaire C;Segars J;Williams C;Tomasetti C;Boyd N;Kinzler KW;Gilks CB;Diaz L;Wang TL;Vogelstein B;Yong PJ;Huntsman DG;Shih IM
通讯作者:
Shih IM
影响因子:
5.6
作者:
Djordjevic, Bojana;Clement-Kruzel, Stacia;Malpica, Anais
通讯作者:
Malpica, Anais
影响因子:
6.4
作者:
Turashvili G;Grisham RN;Chiang S;DeLair DF;Park KJ;Soslow RA;Murali R
通讯作者:
Murali R
影响因子:
7.3
作者:
Ardighieri, Laura;Zeppernick, Felix;Hannibal, Charlotte G.;Vang, Russell;Cope, Leslie;Junge, Jette;Kjaer, Susanne K.;Kurman, Robert J.;Shih, Ie-Ming
通讯作者:
Shih, Ie-Ming